Upload
nadha-noedha-eno-witaroli
View
21
Download
0
Tags:
Embed Size (px)
DESCRIPTION
Materi kuliah dokter yusra
Citation preview
Yusra Pintaningrum
WHO 1999
JNC VII
ETIOLOGY
MECHANISM OF PRIMARY
HEMODYNAMIC SUBTYPE
Neurohormonal control of blood pressure
Blood pressure = Cardiac output (CO) x Peripheral resistance (PR)
Hypertension = Increased CO and/or Increased PR
Preload
Fluid volume
Renal sodiumretention
Contractility
Fluid volume
Vasoconstriction
Sympatheticnervoussystem
Renin-angiotensin-aldosterone
system
Geneticfactors
Excesssodiumintake
(Adapted from Kaplan, 1994)
Acute neurohormonal effects on blood pressure homeostasis
Acute neurohormonal effects on blood pressure homeostasis
Heart rate and cardiac output
Perfusion
Sodium and water retention
Blood pressure
RAA SNS
Chronic neurohormonal effects on vascular structure
Chronic neurohormonal effects on vascular structure
Myocardial hypertrophy
Perfusion
Glomerular hypertention and hypertrophy
Vascular hypertrophy
RAA SNS
Haemodynamic Transition from Hyperkinetic to Typical Essential Hypertension
Cardiaccompliance
Beta adrenergicresponsiveness
Strokevolume Heart rate
CARDIAC OUTPUT
Wall/lumenratio
Endothelialdamage
Vaso-constriction Vasodilation
VASCULAR RESISTANCE
HEART RESISTANCE ARTERIOLES
PATOPHYSIOLOGY
The factors affecting cardiac output: - sodium intake, renal function, & mineralocorticoids - the inotropic effects occur via extracellular fluid volume augmentation - an increase in heart rate and contractility
Peripheral vascular resistance is dependent upon the sympathetic nervous system, humoral factors, and local autoregulation
(Sharma, 2003)
NEURAL MECHANISM
VASCULAR MECHANISM
HORMONAL MECHANISM
Diagnosis Approach
"The Goal is to Get to Goal!”
Hypertension -PLUS- Diabetes or Renal Disease
< 140/90 mmHg < 130/80 mmHg
Patients should return for follow-up and adjustment of medications every 1-2 months until the BP goal is reached
Algorithm for Treatment of Hypertension
Not at Goal Blood Pressure (<140/90 mmHg) (<130/80 mmHg for those with diabetes or chronic kidney disease)
Initial Drug Choices
Drug(s) for the compelling indications
Other antihypertensive drugs (diuretics, ACEI, ARB, BB, CCB)
as needed.
With Compelling Indications
Lifestyle Modifications
Stage 2 HTN (SBP >160 or DBP >100 mmHg)
2-drug combination for most (usually thiazide-type diuretic and
ACEI, or ARB, or BB, or CCB)
Stage 1 HTN (SBP 140–159 or DBP 90–99 mmHg)
Thiazide-type diuretics for most. May consider ACEI, ARB, BB, CCB, or
combination.
Without Compelling Indications
JNC 7 Express. JAMA. 2003 Sep 10; 290(10):1314
Not at Goal Blood Pressure
Optimize dosages or add additional drugs until goal blood pressure is achieved.
Consider consultation with hypertension specialist.
Follow-up and Monitoring
Patients should return for follow-up and adjustment of medications every 1-2 months until the BP goal is reached
After BP at goal and stable, follow-up visits at 3- to 6-month intervals More frequent visits for stage 2 HTN or with
complicating comorbid conditions Continue to encourage self BP monitoring
Serum potassium and creatinine monitored 1–2 times per year
JNC 7 Express. JAMA. 2003 Sep 10; 290(10):1314